Last updated on November 2013

Minerva Pivotal Trial


Brief description of study

Minerva Pivotal Trial

Detailed Study Description

The study gathers information about a new medical device that has been developed to perform endometrial ablations. Women who suffer from excessive menstrual bleeding are randomized to the new device or a control device used to perform the endometrial ablation. Patients are followed for 3 years after the procedure.

Clinical Study Identifier: TX137376

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )